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ARTICLE
The hydrolase LpqI primes mycobacterial
peptidoglycan recycling
Patrick J. Moynihan 1, Ian T. Cadby1, Natacha Veerapen1, Monika Jankute1, Marialuisa Crosatti2,
Galina V. Mukamolova2, Andrew L. Lovering1 & Gurdyal S. Besra 1
Growth and division by most bacteria requires remodelling and cleavage of their cell wall. A
byproduct of this process is the generation of free peptidoglycan (PG) fragments known as
muropeptides, which are recycled in many model organisms. Bacteria and hosts can harness
the unique nature of muropeptides as a signal for cell wall damage and infection, respectively.
Despite this critical role for muropeptides, it has long been thought that pathogenic myco-
bacteria such as Mycobacterium tuberculosis do not recycle their PG. Herein we show that M.
tuberculosis and Mycobacterium bovis BCG are able to recycle components of their PG. We
demonstrate that the core mycobacterial gene lpqI, encodes an authentic NagZ β-N-acet-
ylglucosaminidase and that it is essential for PG-derived amino sugar recycling via an unusual
pathway. Together these data provide a critical ﬁrst step in understanding how mycobacteria
recycle their peptidoglycan.
https://doi.org/10.1038/s41467-019-10586-2 OPEN
1 Institute of Microbiology and Infection, School of Biological Sciences, University of Birmingham, Birmingham B15 2TT, UK. 2 Leicester Tuberculosis Research
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The cell wall of Mycobacterium tuberculosis is built upon afoundation of peptidoglycan (PG). The remainder of thisstructure is formed by the modiﬁcation of muramic acid
residues with an arabinogalactan polymer that is in turn esteriﬁed
by mycolic acids1. This waxy coating not only contributes to drug
resistance in M. tuberculosis, but is also the target of several
mycobacteria-speciﬁc antibiotics1. The challenge of multi- and
extensively drug-resistantM. tuberculosis has not adequately been
met by drug discovery efforts, however, recent reports suggest
that β-lactams are effective in treating these drug-resistant
infections2–4. Despite their therapeutic promise, we know rela-
tively little about the turnover of PG in mycobacteria, which is the
eventual target of β-lactam antibiotics5.
For most bacteria, maintenance of a PG sacculus is an essential
aspect of life. PG is a heteropolymer comprised of glycan chains
with a repeating disaccharide motif of N-acetylglucosamine
β1→4 N-acetylmuramic acid (GlcNAc-MurNAc), which are then
cross-linked to one another via short peptides attached to the C-3
D-lactyl moiety of MurNAc (Fig. 1a). The integrity of this mac-
romolecule must be maintained under most growth conditions
and its rupture leads to lysis and cell death6. As a result of this
essentiality, it is vital that cells are able to withstand their own
internal turgor pressure and still be able to cleave the cell wall to
allow for division, growth, and the insertion of macromolecular
structures such as secretion systems6. Throughout this process,
the activity of lytic enzymes or through the attack of host agents
like lysozyme, the sacculus is cleaved with the resulting genera-
tion of small PG fragments7.
In Gram-positive bacteria, muropeptides are typically released
from the cell wall through the action of lysozyme-like hydrolytic
enzymes, whereas in Gram-negative bacteria, lytic transglycosy-
lases generate 1,6-anhydroMurNAc products8,9. These metabo-
lites have been shown to be important in many aspects of
host-pathogen interactions. For example, tracheal cytotoxin
produced by Bordetella pertussis is the product of lytic transgly-
cosylases10. Release of a similar molecule has also been shown to
be involved in tissue damage during Neisseria gonorrhoeae
infection and in the closure of the light-organ of the bobtail
squid11,12. In many organisms, soluble PG acts as a potent
immune stimulator once sensed by NOD receptors and other
pattern recognition receptors13.
Aside from host organisms, PG metabolites are also important
signalling molecules for the bacteria themselves. Recycling of PG
has been studied in great detail in a small number of organisms
including Escherichia coli, Pseudomonas aeruginosa, and Bacillus
subtilis among others14. The recycling pathway typically involves
the step-wise degradation of the polymer into its monomeric
constituents, monosaccharides, and amino acids (Fig. 1b). Despite
common biochemical steps, compartmentalisation of these steps
tends to be organism speciﬁc8. The resulting monosaccharides are
eventually phosphorylated and MurNAc-6-phosphate is con-
verted into glucosamine-6-phosphate through the activities of
cytoplasmic MurQ and NagA enzymes (Fig. 1b). At the same
time, the stem peptides are degraded to smaller components and
typically shunted back into PG biogenesis. Growth on MurNAc as
a sole carbon source has never been demonstrated for a bacterium
that lacks MurQ. Furthermore, recycling of MurNAc in a bac-
terium that lacks MurQ has only been described in Pseudomonas
putida, and many bacteria, including mycobacteria, are not
thought to recycle their PG at all15.
In the present study, we sought to determine whether
mycobacteria are capable of recycling their PG and if so, what
impact this has on the bacterium. We demonstrate that
these bacteria do indeed possess the biochemical capacity to
recycle PG elements and determined how the bacteria generate
free MurNAc for recycling. Our data indicate that loss of a key
recycling enzyme, LpqI, leads to increased antibiotic and lyso-
zyme resistance.
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Results
PG-recycling genes in mycobacteria. The genome of M. tuber-
culosis encodes many lytic enzymes, including at least ﬁve
resuscitation-promoting factors (Rpfs) and > 10 peptidases and
amidases in addition to penicillin-binding proteins with potential
lytic activities16. The Rpfs are most likely lytic transglycosylases
with the product of RpfB having been recently conﬁrmed as a
GlcNAc-1,6-anhydroMurNAc disaccharide-peptide17. Although
M. tuberculosis does appear to encode at least one lysozyme,
Rv2525, its activity has not been demonstrated18. A recent
comparative study of PG-active enzymes in mycobacteria indi-
cated that although signiﬁcant differences exist, enzymes that can
likely degrade all of the major covalent linkages of PG are
encoded in the genomes of all mycobacteria16. The products of
most of these enzymes have not been experimentally demon-
strated, however, their conservation underscores the importance
of PG-remodelling during growth and division of mycobacteria.
Most autolytic enzymes produce small PG metabolites
(muropeptides), indicating that mycobacteria should generate
these molecules during the course of normal growth. Indeed,
soluble PG fragment release has been observed for both M.
smegmatis andM. tuberculosis in vitro19,20. Given the slow release
of PG fragments by mycobacteria, we evaluated the presence of
known PG-recycling systems in the genome of several coryne-
bacterial species (Supplementary Table 2)15,21. BLAST analysis of
the Corynebacterium glutamicum, M. tuberculosis, Mycobacter-
ium leprae, and M. bovis BCG genomes indicates that they lack
genes related to any known muropeptide import proteins, PG-
metabolite phosphorylation systems, and murQ. The only sugar-
kinase orthologs identiﬁed in the genome have previously been
characterised as glucose-kinases although they have not been
directly tested for amino sugar-phosphotransferase activity22.
This contrasts sharply withM. smegmatis for which an apparently
complete “classical” muropeptide recovery system exists, making
it a poor model for the PG metabolism of M. tuberculosis
(Supplementary Table 2). Taken together, the available data
indicates that M. tuberculosis and almost all other mycobacteria
lack most of the known PG-recycling genes from other bacteria,
with only two conserved genes potentially associated with PG-
recycling, (nagA—Rv3332, nagZ/lpqI—Rv0237).
Biochemical and structural characterisation of LpqI. In pre-
viously characterised PG-recycling systems free amino sugars are
produced by NagZ, which belongs to the CAZy glycoside
hydrolase family 3 (GH3)23. This family is a large group of
enzymes that have hydrolytic and phosphorylytic activity and
remove β-linked sugars from proteins and polysaccharides24,25.
The β-N-acetylglucosaminidase sub-family including all known
NagZ enzymes utilise a conserved Asp-His catalytic dyad, which
has been well characterised26,27. A BLAST search of the M.
tuberculosis H37Rv genome revealed only one NagZ ortholog,
which was previously named LpqI in light of its identiﬁcation as a
lipoprotein including an appropriately positioned lipobox at the
N-terminus of the protein28. As a lipoprotein LpqI is expected to
be found attached to the external face of the cytoplasmic mem-
brane, which is consistent with proteomics results28. LpqI has also
been identiﬁed as a likely mannosylated glycoprotein in a pro-
teomics screen using ConA chromatography29. The lpqI gene is
found in all mycobacteria with sequenced genomes including M.
leprae, which has a substantially reduced genome suggesting that
it is involved in a conserved process across all mycobacteria
(Supplementary Table 2, Supplementary Fig. 1).
Given the absence of other PG-recycling-associated genes, we
sought to identify the function of LpqI. Although LpqI bears
signiﬁcant sequence similarity to known β-N-acetylglucosaminidases,
recent studies have demonstrated that divergent activities for this
sub-family of enzymes are possible25. These activities included the
ability to release sugars other than GlcNAc from reporter substrates
and apparent phosphorolytic activity. To test this, we cloned,
expressed and puriﬁed LpqITB using an N-terminal His6-SUMO
tag, which was subsequently cleaved from the protein. We ﬁrst
determined whether the protein was in fact a β-N-acetylgluco-
saminidase by testing its activity on a variety of substrates
including many sugars that would be found in the cell wall of
mycobacteria. Using convenient reporter sugars we assessed the
ability for the enzyme to release p-nitrophenolate or 4-
methylumbeliferone from a variety of conjugated sugars (Fig. 2a).
Although not exhaustive, this set of sugars covers most major
modiﬁcations to the cell wall including the AG itself, O-mannose
modiﬁcations of proteins, GalN modiﬁcation of arabinan, the
rhamnose-linker sugar of AG and the GlcNAc and GlcN found in
PG. The only detectable activity for LpqI was with GlcNAc-
containing substrates (Fig. 2a). Critically, in mycobacteria, this
sugar is limited to the backbone of PG and a small amount in the
linker unit (MurNAc-6-P-Rha-GlcNAc-galactan) between PG
and arabinogalactan. The Michaelis–Menten constants (kcat=
2.0 × 10–2 ± 0.04 × 10–2 s−1 and Km= 72 ± 5 µM) of LpqI using
4MU-GlcNAc as a substrate were found to be similar to other
NagZ enzymes using this substrate (Fig. 2b)26. In a similar assay
we were also able to show that LpqI releases GlcNAc from soluble
PG fragments (Fig. 2c), including PG fragments with a 1,6-
anhdroMurNAc terminus (Supplementary Fig. 2). Although
hydrolytic activity has been reported for most NagZ-type
enzymes, a recent report suggested that β-N-acetylglucosamini-
dases from the GH3 family are in fact phosphorylases25. Another
GH3 β-N-acetylglucosaminidase was recently reported to lack
this latter activity, suggesting that it may not be a general
property of the family30. We tested the activity of the enzyme
under the same conditions as reported previously (50 mM sodium
phosphate buffer, pH 7.0, 300 mM NaCl, 5 mM MgSO4, 10%
glycerol, 1 mM DTT) for Nag3 from Celulomonas ﬁmi and found
that there was no detectable difference with our observed
hydrolytic activity. The product of the reaction also co-
migrated with GlcNAc on TLCs and not GlcNAc-1-P (Supple-
mentary Fig. 3).
To conﬁrm that LpqI is an exo-acting enzyme rather than an
autolytic β-N-acetylglucosaminidase we evaluated the activity of
the enzyme using deﬁned-length chitooligosaccharides. As shown
in Supplementary Fig. 4a, LpqI produces GlcNAc5 and GlcNAc
from GlcNAc6. This is in contrast to the known endo-acting
chitinase ChitB, which produces GlcNAc2 and GlcNAc4 from the
same substrate31. We further tested the ability of the enzyme to
act as an autolysin and release soluble PG from insoluble material
by incubating the enzyme with ﬂuorescently labelled PG. In this
assay, LpqI was not observed to release any soluble PG in contrast
to the muramidase mutanolysin (Supplementary Fig. 4b).
Together these data support the role of LpqI as an exo-acting
enzyme involved in fragment recycling, rather than as an endo-
acting autolysin.
To further conﬁrm its function and validate its role in PG-
recycling, we solved the 1.96Å X-ray crystal structure of LpqI
(PDB code: 6GFV; Supplementary Fig. 1, Supplementary Table 3).
LpqI consists of a single TIM-barrel domain similar to
cytoplasmic Gram-negative orthologs but lacks the C-terminal
domain associated with extracellular NagZ enzymes from some
Gram-positive bacteria (Supplementary Fig. 5). Alignment of
LpqI with the NagZ/GlcNAc/1,6-anhydroMurNAc complex from
P. aeruginosa (NagZPa; PDB:5G3R) or NagZ from B. subtilis
(PDB:4GYJ) using the SSM Superpose function in COOT resulted
in a root-mean-square deviation of 2.30Å and 1.63Å, respec-
tively (Supplementary Fig. 5). Superposition of the post-cleavage
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NagZPa complex with LpqI indicates that the appropriate
coordinating residues for MurNAc or 1,6-anhydroMurNAc
recognition are intact in LpqI, supporting its role in PG-
recycling (Fig. 2d)32.
LpqI-catalysed utilisation of PG components by mycobacteria.
Having conﬁrmed the in vitro activity of LpqI, we sought to
determine the fate of its reaction products, MurNAc and GlcNAc,
in growing M. bovis BCG. Prior research has shown that most
mycobacteria are unable to use GlcNAc as a sole carbon source,
with M. smegmatis being one of the notable exceptions33. Amino
acids including D-Ala and D-Glu have previously been shown to
serve as nitrogen sources for M. tuberculosis H37Rv but they
do not serve as carbon sources34. L-Ala has also been shown to
not serve as a carbon source for M. bovis35. To our knowledge,
recycling of GlcNAc or MurNAc by mycobacteria has not been
reported, nor has recycling been tested for soluble PG fragments.
To evaluate this, M. bovis BCG was cultured in minimal media
supplemented with glycerol (1% v/v) or MurNAc (0.2% w/v) in
Sauton’s minimal media with constant aeration. As observed in
Fig. 3a, M. bovis BCG was able to grow using MurNAc as a sole
carbon source. To conﬁrm that this was not a phenotype speciﬁc
to M. bovis BCG we also evaluated the ability of M. tuberculosis
H37Rv to grow on the same carbon sources with identical results
(Fig. 3b). Intriguingly growth on MurNAc in broth was heavily
dependent on the aeration of the culture. In contrast, growth on
glycerol was unaffected by this change (Fig. 3c). To further
evaluate the potential for mycobacteria to take up GlcNAc but
use it for purposes other than central metabolism, we tested the
ability of M. bovis BCG to incorporate 14C GlcNAc into whole
cells. Under different growth conditions (rich medium, carbon-
poor medium, aerated cultures, static cultures) we were unable to
detect signiﬁcant amounts of GlcNAc being taken up by M. bovis
BCG. In all cases, the c.p.m. of the label in whole cells was less
than or equal to unlabelled controls. We conclude from these data
that pathogenic mycobacteria are able to utilise MurNAc, but not
GlcNAc in an O2-dependent fashion.
Mechanism of MurNAc metabolism. Given its structural simi-
larity to GlcNAc, the ability of M. tuberculosis and M. bovis BCG
to grow on MurNAc was surprising and so we evaluated the
biochemical processing steps associated with MurNAc utilisation.
MurNAc is a combination of GlcNAc and D-lactate joined by an
ether linkage. This suggests that the bacterium is either using the
GlcNAc moiety for glycolysis, or shunting the lactate derived
from MurNAc into the TCA cycle. We tested this by inhibiting
glycolysis with 2-deoxyglucose in cultures grown using MurNAc,
glucose, and glycerol as sole carbon sources (Supplementary
Fig. 6). These data suggested that the pathway of MurNAc utili-
sation did not require glycolysis and indicated that the lactate
1,6-anhydroMurNAc
GlcNAc
H174Pa
D172Pa
D244Pa
R70Pa
H238TB
D236TB
D313TB
R133TB
D119Pa
D182TB
H162Pa
H226TB
R131Pa
R195TB
R130TB
R67Pa
Val345TB
Asn276Pa
D62Pa
D125TB
Catalytic His
Catalytic
Asp
GlcNAc
Glc
NA
c
–
Lp
qI
+L
pq
I
Soluble
M. smegmatis
PG
0.0
0.5
1.0
1.5
2.0
V 0
 
(nm
ols
 
·
 
s–
1 )
0 100 200 300 400 500
[4MU-GlcNAc] (μM)
KM = 72 ± 5 μM 
kcat = 2.0 × 10–2 ± 0.04 × 10–2 s–1
n
m
o
l 4
M
U 
or
 p
NP
0.0
0.5
1.0
Time (min)
2 4 6 80
4MU-α-L-Araf
4MU-β-D-Glucp
4MU-β-D-GalNAc
4MU-β-D-GlcNAc
pNP-β-D-Fucp
pNP-β-D-Galp
pNP-α-Manp
pNP-α-Rhamp
a b
c d
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and release of pNP or 4MU was followed by absorbance or ﬂuorescence respectively. Cleaveage of 4MU-GlcNAc is indicated by blue triangles. b LpqI was
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moiety of MurNAc, was instead most likely serving as a carbon
source. Consistent with this, when used as a sole carbon source,
growth on L-lactate and MurNAc was O2-dependent, whereas
D-lactate was better utilised under static, 5% CO2 culture condi-
tions, where MurNAc could not be used as a carbon source
(Fig. 3c).
These data allow us to hypothesise a mechanism by which M.
bovis BCG metabolises MurNAc. Given that metabolism of
L-lactate and MurNAc are O2-dependent, we anticipate that use of
MurNAc follows cleavage of the D-lactate from MurNAc to
produce lactate and GlcNAc. In this case, the O2 dependency on
MurNAc metabolism is likely the result of an O2-dependent
lactate dehydrogenase. Consistent with this, two O2-dependent L-
lactate dehydrogenases have been identiﬁed in M. tuberculosis
(Rv0694, Rv1872c), which are required for growth on L-lactate as
a sole carbon source36. Given the unusual nature of MurNAc,
generation of free lactate by the bacterium would require the
activity of a speciﬁc lactyl-etherase. To test for the presence of this
activity in whole cells, we synthesised a 4MU-D-lactate derivative
to serve as a reporter-analogue of MurNAc (Supplementary
Fig. 7). Consistent with the presence of a lactyl-etherase, cultures
of M. bovis BCG were able to release 4MU from this compound
during the course of growth (Fig. 3d). Together these data
support a model where mycobacteria cleave the lactyl moiety
from MurNAc by an as-yet unidentiﬁed enzyme and utilise the
product of that reaction as a carbon source under aerated
conditions.
LpqI-dependent uptake of PG metabolites by mycobacteria.
Although our data strongly support metabolism of MurNAc by
M. bovis BCG, we wanted to conﬁrm the role of LpqI in myco-
bacterial PG-recycling. To do this we constructed a mutant strain
of M. bovis BCG-lacking lpqI using specialised transduction37. To
validate that LpqI is the only β-N-acetylglucosaminidase pro-
duced by M. bovis BCG, we used a whole-cell β-N-acet-
ylglucosaminidase assay. This demonstrated that M. bovis BCG
Δlpqi is devoid of β-N-acetylglucosaminidase activity as the
amount of 4MU released is not signiﬁcantly different from the
spontaneous release in sterile media (Fig. 4a). This deﬁciency is
complemented by re-introduction of the lpqI gene at a distal
chromosomal location under the control of its native promoter
(ΔlpqI::lpqI) and is not complemented by the empty vector
(ΔlpqI::EV) (Fig. 4a). Growth of ΔlpqI in vitro is also unaltered as
compared to the wild-type (Fig. 4b). This mutant therefore pro-
vided us with an opportunity to probe the role of disaccharide
cleavage in mycobacterial PG-recycling.
The order in which muropeptides are recycled, and the
chemical structure of the recycled material is critical for the
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containing glycerol (blue diamonds), MurNAc (orange triangles), or no carbon (grey circles) and growth was monitored daily by taking OD600 readings at
the indicated time points (n= 3; error bars are ± SD). b M. tuberculosis H37Rv was washed and then serially diluted into fresh carbon-free minimal media.
10 μL of each dilution was spotted onto Sauton’s agar containing the indicated carbon sources at 5 mM. c Growth of M. bovis BCG on 5mM MurNAc,
GlcNAc, L-lactate, D-lactate, and glycerol was evaluated in aerated (blue) or static 5% CO2 (orange) cultures using a resazurin assay (n= 3; error bars are
± SD). d Mid-exponential M. bovis BCG was grown in minimal media with 5mM glycerol including 1 mM 4MU-D-lactate (blue circles) with constant
agitation. At the indicated times, the 4MU ﬂuorescence of the samples was determined in a BMG Polarstar plate reader (n= 3; error bars are ± SD) and
compared with controls without cells (orange squares) or without 4MU-D-lactate (grey triangles)
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immune sensing of the bacterium. To determine the order of PG-
recycling steps, we ﬁrst assessed the impact of the loss of lpqI on
the recycling of cell wall material. To investigate this, we
generated radio-labelled muropeptides and tested them in
whole-cell uptake assays. Radio-labelled muropeptides had to be
generated in M. smegmatis mc2155 owing to the inability of M.
bovis BCG to take up 14C GlcNAc under the conditions we tested.
As shown in Supplementary Fig. 8, the M. bovis BCG ΔlpqI
mutant took up ~ 25% less of the labelled PG than the wild-type
(~ 3% vs. ~ 4%, respectively). In a similar assay using PG
fragments labelled with 3H diaminopimelic acid (DAP) the
mutant did take up slightly less of the PG than the wild-type,
however this difference was not found to be signiﬁcant using a
two-tailed t test (Supplementary Fig. 8). To probe this result
further, we pre-labelled cells with 3H DAP and monitored the
release of the label into the culture media. Supporting the data
above, we observed no signiﬁcant differences between the wild-
type and the ΔlpqI strain with respect to the amount of label
released to the media (Fig. 4b). From these experiments, we
concluded that LpqI is involved in amino sugar recovery but is
not required for stem-peptide recycling.
Given the inability of M. bovis BCG to take up radiolabeled
GlcNAc we were unable to repeat the previous experiment using
14C GlcNAc and follow release of this sugar to the media. To
unambiguously test the impact of deleting lpqI on amino sugar
recycling by the bacterium, we evaluated its ability to grow on
MurNAc, GlcNAc-MurNAc and PG from both wild-type M.
smegmatis mc2155 and ΔnamH strain, which lacks the char-
acteristic N-glycolyl modiﬁcation of MurNAc (Fig. 4c). The ΔlpqI
strain was not deﬁcient for growth on MurNAc, however unlike
the wild-type strain it was unable to grow on GlcNAc-MurNAc
and exhibited only very weak growth on soluble PG as a sole
carbon source (Fig. 4c). This growth was rescued by pre-digestion
of the muropeptides with LpqI (Fig. 4c). Together these data
indicate that lpqI is required for PG-derived amino sugar
recycling in M. bovis BCG.
Phenotypic characterisation of a ΔlpqI mutant. As indicated
above, loss of LpqI did not alter the growth rate of the bacterium
in vitro. However, given that NagZ-like proteins have been found to
play a role in β-lactam sensitivity in other bacteria we sought to
determine the antimicrobial sensitivity of the ΔlpqI strain. In con-
trast to inhibition of P. aeruginosa NagZ, deletion of lpqI resulted in
an increase in survival in the presence of lysozyme and all cell wall
active antibiotics tested (Fig. 5a–d)38. A smaller impact on survival
in the presence of the protein synthesis inhibitor chloramphenicol
was observed (Fig. 5e). This increase in resistance is not owing to a
change in cell wall permeability as determined by ethidium bromide
uptake (Fig. 5f). These data indicate that lpqI-dependent amino
sugar recycling is involved in the expression of antibiotic and
lysozyme resistance by mycobacteria in vitro.
Discussion
In an attempt to develop diagnostic media for the identiﬁcation of
mycobacteria, several groups in the 1960s observed that M.
tuberculosis and most other mycobacteria could not metabolise
GlcNAc as a sole carbon source33,34. This, along with the absence
WT
ΔlpqI
ΔlpqI::lpqI
ΔlpqI + LpqI
WT PGΔnamH PGGlcNAc-MurNAcMurNAc
Fl
uo
re
sc
en
ce
 (A
U 
× 1
04
)
0.5
1.0
1.5
2.0
0
**
**
n.s.
Media
Wall
WT
ΔlpqI
0 5 10
0.1
1
10
0
20
40
60
80
100
Time (days)
O
D 6
00
%
 T
o
ta
l 3
H
 D
A
P
b
c
a
0
5
10
15
WT Δlp
qI
Δlp
qI:
:lp
qI
Me
dia
Fl
uo
re
sc
en
ce
 (A
U 
× 1
04
) ***
n.s.
n.s.
Δlp
qI:
:EV
Fig. 4M. bovis BCG is able to recycle PG. aM. bovis BCGWT, ΔlpqI, ΔlpqI::lpqI and ΔlpqI::Empty Vector were incubated with 1 mM 4MU-GlcNAc in minimal
media. After 3 days the ﬂuorescence of the cultures were measured (n= 3; error bars are ± SD). b M. bovis BCG WT (grey diamonds) and ΔlpqI (red
triangles) were simultaneously evaluated for release of cell wall peptides and growth (n= 3; error bars are ± SD). cM. bovis BCGWT (dark grey bars), ΔlpqI
(red bars), and ΔlpqI::lpqI (light grey bars) were evaluated for their growth using MurNAc (5mM), GlcNAc-MurNAc (2mM), soluble PG from M.
smegmatis mc2155 wild-type or ΔnamH (5 and 2.5 mM, respectively), and soluble PG, which had been pre-digested wth LpqI (striped bars) as sole carbon
sources using a resazurin assay (n= 3; ***= p < 0.001; **= p < 0.005). Statistical signiﬁcance determined using a two-tailed t-test in GraphPad Prism 7
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10586-2
6 NATURE COMMUNICATIONS |         (2019) 10:2647 | https://doi.org/10.1038/s41467-019-10586-2 | www.nature.com/naturecommunications
of known PG recycling-associated genes lead to the assumption
that PG recycling is absent in pathogenic mycobacteria. Based on
our data and the literature, it is clear that not only is M. tuber-
culosis able to recycle its PG, it is generating two distinct classes of
molecules. These are GlcNAc-MurNAc-peptide, which is sensed
by the host, and GlcNAc-MurNAc that is sensed by the bacter-
ium. Although host-sensing of PG is unaffected by the presence
of GlcNAc on NOD-stimulatory molecules, our data indicate that
LpqI acts as a regulator for GlcNAc-MurNAc levels by cleaving
disaccharides and allowing the breakdown of MurNAc. In other
bacteria, cell wall damage can trigger various stress responses, and
so it is likely that a build-up of GlcNAc-MurNAc disaccharides
may trigger a stress-like response in mycobacteria39. Consistent
with this, lpqI is encoded adjacent to a universal stress response
protein in several species of mycobacteria (Supplementary Fig. 1).
As a starting point to investigate PG recycling in M. tubercu-
losis, we characterised the core mycobacterial protein, LpqI.
Despite the absence of other known PG-recycling proteins, we
have shown that LpqI is an authentic exo-acting β-N-acet-
ylglucosaminidase, which is able to cleave PG fragments in vitro.
Consistent with a role in PG-recycling, M. bovis BCG ΔlpqI is
unable to grow on soluble PG as a sole carbon source, whereas
recycling of the stem-peptide is unaltered in this mutant. Toge-
ther, our data demonstrate thatM. bovis BCG andM. tuberculosis
remove the stem-peptide from PG fragments prior to dis-
accharide cleavage and lactyl-ether removal (Fig. 6). The
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processing of GlcNAc-MurNAc by LpqI prior to lactyl-ether
cleavage is also supported by our LpqI crystal structure in which
the lactate-binding residue R67 from the P. aeruginosa structure
is conserved (LpqI: R130), suggesting that the physiological
substrate of this enzyme possesses the lactyl group32.
Our sole carbon source assays indicate that although the bac-
teria are unable to metabolise GlcNAc, surprisingly they can use
MurNAc as a sole carbon source (Fig. 3). This is despite the fact
that they lack an ortholog of the only known lactyl-etherase,
MurQ that cleaves an otherwise stable lactyl-ether in the cyto-
plasm of most model organisms (Fig. 1). Our data indicate that
rather than using the GlcNAc portion of the MurNAc, the bac-
teria are cleaving the lactyl-ether and metabolising the liberated
lactate. During our study we found that M. bovis BCG was only
able to grow on MurNAc under aerated conditions. This was also
found to be the case for L- but not D-lactate, which served as a
much better carbon source under O2- limiting conditions. This
suggests that L-lactate is likely the metabolised product of this
reaction. The presence of a speciﬁc lactyl-etherase is further
supported by the turnover of a 4MU-D-lactate reporter com-
pound by M. bovis BCG. The O2 dependence of growth on
MurNAc is intriguing as N-glycolylation is also an O2-dependent
activity, suggesting signiﬁcant alterations to PG metabolism in
hypoxic vs. aerobically growing mycobacteria40. Consistent with
this observation, expression of lpqI is upregulated twofold during
re-aeration after re-activation from non-replicating persistence in
the Wayne hypoxia model41.
The fate of GlcNAc in this pathway remains unclear, although
our data and prior observations suggest that the bacteria do not
re-use this sugar. The inability to utilise this sugar is surprising
given the conservation of the nagA (Rv3332) gene in myco-
bacteria42. However, it is possible that an alternative GlcNAc-
recovery pathway exists that was not functional under the
conditions we have tested. This is hinted at, with our 14C-labelled
muropeptides, where incorporation of the labelled-GlcNAc is not
expected, given the lack of monomeric GlcNAc utilisation by the
cells. During the production of radio-labelled PG in M. smeg-
matis, a portion of the GlcNAc will have been used by the bac-
terium to generate MurNAc rather than strict shunting of
GlcNAc into UDP-GlcNAc for cell wall biosynthesis. The sub-
sequent removal of the lactyl-ether from this 14C-MurNAc by M.
bovis BCG would then follow steps and intermediates we do not
yet fully understand. Indeed, bacterial etherases comprise a
diverse number of mechanisms and potential reaction products
and so a product other than free GlcNAc is entirely possible43.
We are currently trying to identify and characterise the enzyme
responsible for the observed lactyl-etherase activity.
In conclusion, we have identiﬁed a PG recovery pathway in
pathogenic mycobacteria. We have shown that this occurs in a
step-wise fashion by removing stem-peptide from PG and sub-
sequently cleaving the PG-disaccharide and ﬁnally releasing the
D-lactate from free MurNAc. Finally, we have shown that recy-
cling of PG by these bacteria is important for lysozyme and
antibiotic resistance.
Methods
Bacterial strains and growth conditions. Unless stated otherwise, all chemicals
and reagents were purchased from Sigma Aldrich. M. tuberculosis H37Rv, M. bovis
BCG (Pasteur), and related mutants were maintained on Middlebrook 7H10 agar
or 7H9 broth supplemented with 10% OADC enrichment and 0.05% Tween 80.
Appropriate kanamycin or hygromycin was added at 25 or 50 μg mL−1, respec-
tively. Mycobacterium smegmatis strains mc2155 and mc2155 ΔnamH were
maintained on Tryptic Soy Broth or Tryptic Soy Agar where appropriate40. For
growth on deﬁned carbon sources, strains were cultivated in Sauton’s minimal
medium containing per 1 L, 4 g asparagine, 2 g citric acid, 0.5 g K2HPO4, 0.5 g
MgSO4 * 7 H2O, and 0.05 g ferric ammonium citrate, 0.05% tyloxopol and 5 mM of
each carbon source unless stated otherwise44. E. coli strains were grown in
lysogeny broth and supplemented with kanamycin at 50 μg mL−1 or hygromycin at
150 μg mL−1 where appropriate. GlcNAc-MurNAc was purchased from Toronto
Research Chemicals.
Cloning and puriﬁcation of LpqITB. The gene encoding LpqI (Rv0237) was
ampliﬁed from M. tuberculosis H37Rv genomic DNA using standard PCR con-
ditions with the lpqITBSUMOF and lpqITBSUMOR primers and cloned into the T-
A site of the Champion pET-SUMO expression plasmid (Invitrogen) according to
the manufacturer’s speciﬁcations (all primers are found in Supplementary Table 1).
For production of LpqI 1 L of E. coli BL21 [pLpqITB] grown in Terriﬁc Broth to an
OD600 of 0.6, chilled to 20 °C and induced with 1 mM IPTG and grown for a
further 18 h before being collected by centrifugation. Cells were resuspended in
25 mM Tris-HCl, 300 mM NaCl, 10 mM imidazole pH 7.8 and lysed via three
passages through a French pressure cell. The protein was puriﬁed using standard
IMAC procedures with washes of lysis buffer, lysis buffer including 50 mM imi-
dazole and ﬁnally eluted with 500 mM imidazole in lysis buffer. Eluted protein was
dialysed exhaustively against 25 mM Bis-Tris, 100 mM NaCl pH 7.8 in the presence
of recombinant Ulp1 protease, which speciﬁcally cleaves the His6-SUMO tag.
Digested protein was passed through a second IMAC column (1 mL HisTrap FF,
GE Healthcare) and the ﬂow-through fraction was found to contain pure, un-
tagged LpqI. Puriﬁed protein was dialysed into 25 mM Bis-Tris pH 6.5,
100 mM NaCl.
Cloning and puriﬁcation of RpfB. RpfB was cloned according to the same pro-
cedure as LpqI using the primers RpfBFwd and RpfBRev. Expression and pur-
iﬁcation was achieved using the same general procedure as LpqI.
Crystallography. Prior to crystallisation, LpqI was concentrated to 20 mgmL−1 in
25 mM Bis-Tris pH 7.5, 100 mM NaCl. LpqI crystals were grown by the sitting-
drop vapour diffusion method by mixing an equal volume of protein solution with
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Fig. 6 Peptidoglycan recovery pathway in pathogenic mycobacteria. Based
on our observations we can propose the following model for PG recycling
and recovery in mycobacteria. Cleavage of the cell wall by endogenous
autolysins or host-derived lysozyme generates muropeptides. Some of this
material undergoes limited release to stimulate the host immune system.
The remainder are subsequently degraded by amidases and other
peptidases. LpqI then cleaves GlcNAc-MurNAc, which is followed by
D-lactyl-ether cleavage. Lactate can then be used by the cell under aerobic
conditions and GlcNAc (or its derivatives) are most likely released.
Perturbation of this system by deleting LpqI leads to increased resistance to
anti-mycobacterial agents
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1.1 M sodium malonate, 0.1 M HEPES, 0.5% w/v Jeffamine ED-2001 (pH 7.0).
Crystals were cryo-protected with a saturated solution of sodium malonate and
ﬂash-cooled in liquid nitrogen. X-ray data were collected at beamline I04-1 of the
Diamond Light Source, Oxford. Data were auto-processed using Xia2 and general
ﬁle manipulations were performed using the CCP4 suite of programmes45,46. The
structure was phased by molecular replacement using the unpublished M. smeg-
matis LpqI structure (PDB: 4YYF, 67% sequence identity) using the programme
PHASER (TFZ of 17). The structure was subsequently auto-built in PHENIX and
the remaining parts were built in COOT with further reﬁnement using PHENIX
and PDB-REDO47–49.
Kinetic characterisation of LpqI. Puriﬁed LpqI was evaluated for glycoside
hydrolase activity using a variety of substrates. As an initial screening assay, LpqI
was incubated at 1 μM with either 4-methylumbeliferyl (4MU) or p-nitrophenyl
(pNP) derivatives of a variety of sugars (arabinose, galactose, galactosamine, ara-
binofuranose, glucose, mannose, mannosamine, glucosamine, and N-acet-
ylglucosamine) in Bis-Tris pH 7.5, 100mM NaCl at 37 °C. The release of pNP was
followed by change in absorbance at 420 nm, whereas production of 4-
menthylumbelliferone was monitored by ﬂuorescence (Ex. 355 nm; Em 460 nm) in
a BMG Polarstar spectrophotometer. Kinetic characterisation of LpqITB was con-
ducted using varying concentrations of 4MU-GlcNAc. The raw data were compared
to standards of pNP or 4MU. All data were analysed using GraphPad Prism 7.
Substrate speciﬁcity of LpqI. To determine whether LpqI was an endo- or exo-
acting enzyme we incubated 0.1 μM of either LpqI or ChitB (Generon) with 5mM
N,N´,N´´,N´´´,N´´´´,N´´´´´-hexacetylchitohexaose (GlcNAc6) in 25mM phos-
phate buffer pH 6.5. After 3 h, 30 μL the sample was reduced with 10mgmL−1
(ﬁnal) NaBH4 for 30min. The NaBH4 was quenched with 20% phosphoric acid and
the pH reduced to ~ 4. Reaction products were separated by HPLC on a Dionex
UPLC system with a Thermo Hypercarb column (100 × 2.1 mm). Separation was
achieved with a linear gradient from 0.1% triﬂuoroacetic acid (TFA) in H2O to 30%
acetonitrile, 0.1% TFA over 15 min and peaks were detected with absorbance at
210 nm. Peaks were identiﬁed using standards of known length. To determine
whether LpqI could act as an autolysin and cleave insoluble mycobacterial PG we
labelled insoluble PG from M. smegmatis mc2155 with ﬂuorescein isothiocyanate50.
LpqI, mutanolysin or a chitinase were incubated at a ﬁnal concentration of 1 μM
overnight with 1 mgmL−1 FITC-PG conjugate in 25mM sodium phosphate buffer
pH 6.5. The sample was then ﬁltered and the ﬂuorescence of the soluble fraction was
read (Ex. 495, Em, 519) in a BMG Fluorostar plate reader.
Digestion of cell wall material with mutanolysin or RpfB was carried out
overnight at 37 °C in 20 mM ammonium acetate buffer (pH 6.5) with continuous
mixing. Following digestion, solubilised muropeptides were isolated using
graphitised carbon solid-phase-extraction cartridges51. Puriﬁed fractions were
evaporated to dryness and the concentration of reducing sugars in the pool of
soluble muropeptides was assessed using the 3-methyl-2-benzothiazolinone
hydrazone assay52. For RpfB-generated muropeptides the concentration was
estimated gravimetrically using an average molecular weight of 953.41 Da for
GlcNAc-1,6-anhydroMurNGlyc-tetrapeptide.
Reactions including 1 μM LpqITB, and 0.5 mM mutanolysin-derived PG
fragments or 0.1 mM RpfB-derived PG fragments in 25 mM ammonium acetate
buffer pH 6.5 were incubated for 18 h at 37 °C. The reactions were then evaluated
by TLC (Silica 60 F254, Merck, Germany) using a mobile phase consisting of
1-butanol, methanol, ammonium hydroxide and water at a ratio of 5:4:2:1. TLCs
were stained with α-naphthol and developed by charring.
Mutant generation. To generate the ΔlpqI strain we used specialised transduction
according to established protocols37. A recombinant lpqI knockout phage was
designed to replace the chromosomal lpqI gene using homologous ﬂanking regions
to lpqI with a sacB gene and a hygromycin resistance cassette in-between using the
LL-lpqIBCG, LR-lpqIBCG, RR-lpqIBCG, and RL-lpqIBCG primers. The resulting
phage was transduced into M. bovis BCG and transductants were selected on 7H10
agar plates containing 75 μg mL−1 hygromycin. The mutant was veriﬁed by PCR
and phenotypically with 4MU-GlcNAc where loss of lpqI was expected to abolish
turnover of this ﬂuorescent substrate. The complemented strain was generated by
incorporating the lpqI gene and 150 bp 5′ to the start codon containing the pro-
moter sequence into the promoter-less integrative mycobacterial shuttle vector
pMV306 using primers lpqIBCGCompF and lpqIBCGCompR to generate the
resulting pMV306-lpqI plasmid53. This was electroporated into M. bovis BCG
ΔlpqI and transformants were selected on 7H10 agar containing hygromycin and
kanamycin. The complemented mutant was veriﬁed phenotypically with 4MU-
GlcNAc. A control strain was also generated using the empty pMV306 vector using
the same protocols.
Antimicrobial testing. Mid-exponential cultures of M. bovis BCG and derivative
strains were diluted to OD600= 0.1 in fresh 7H9 media. 100 μL of this culture was
added to a 96-well plate with the addition of 1 μL of antibiotic/lysozyme to achieve
the desired ﬁnal concentration as indicated. These were incubated for 7 days at
37 °C at which point 30 μL of 0.02% w/v resazurin and 12.5 μL of 20% Tween
80 v/v was added to the culture. This was incubated overnight at 37 °C and the
production of resoruﬁn was determined by ﬂuorescence (Ex. 530 nm, Em. 590 nm)
using a BMG Polarstar plate reader.
Rapid puriﬁcation of mycobacterial cell wall. Rapid puriﬁcation of cell wall from
small cultures was carried out using a modiﬁed phenol extraction protocol19.
Mycobacterial cells were grown to mid-exponential phase and collected by cen-
trifugation. These were washed with cold phosphate-buffered saline (PBS) and
resuspended in PBS and the cells were lysed in a Percellys Evolution Bead Beater at
5000 rpm for 3 min. The lysate was then transferred to glass culture tubes to which
2 mL of 98% phenol was added and vortexed for 1 min. This was heated for 1 h at
70 °C, allowed to cool and the insoluble material was collected by centrifugation at
3220 × g. The aqueous phase was removed and 4 mL of methanol was added. This
was vortexed and centrifuged again. Finally, the pellet was washed three times with
methanol and once with water before being frozen or used for subsequent enzy-
matic treatment.
Large-scale puriﬁcation of PG. Puriﬁcation of PG from M. smegmatis was
achieved following established protocols54. Six liters of M. smegmatis were grown
with aeration to mid-exponential phase (OD600= ~ 0.6) at which point they were
harvested by centrifugation, resuspended in a minimal volume of PBS and lysed by
sonication. The resulting lysate was brought to 4% sodium dodecyl sulphate (SDS)
and boiled under reﬂux for 3 h. The insoluble material was collected by cen-
trifugation and washed with water until the SDS was completely removed (at least 7
washes) to yield mycolyl-arabinogalactan-peptidoglycan (mAGP). The mAGP was
incubated for 4 days in 0.5% (w/v) KOH in methanol at 37 °C before being washed
three times with methanol. The mycolic acids were extracted with three washes of
diethyl ether. The phosphodiester linking the AG-PG complex was cleaved using
0.2 M H2SO4 and the PG was separated from the solubilized AG by centrifugation
prior to neutralisation with NaCO3 and washed with water three times. The
insoluble PG pellet was sequentially digested with α-amylase (100 μg mL−1), DNase
(10 μg mL−1) and RNase (5 μg mL−1) for 8 h before proteinase K (100 μg mL−1)
digestion overnight at 37 °C. The PG pellet was resuspended in a minimal volume
of 1% SDS and boiled under reﬂux for 3 h before the SDS was removed by cen-
trifugation and washing with water (at least seven times). The resulting material
was lyophilised and stored at − 20 °C until it was needed. Digestion and quanti-
tation of this material was carried out as described above.
Synthesis of 4MU-D-lactate. Instead of the 2- or 3- step protocols published for
the synthesis of 4MU-D-lactate previously, we used a simpliﬁed one step
method55,56. In total, 1.5 g of (s)-(-)-bromopropionic acid was added to 1 g of
4-methylumbelliferone stirring in 40 mL anhydrous dimethylformamide and 0.75 g
Cs2CO3. This was stirred at room temperature overnight and the product was
extracted three times with water/ethyl-acetate and the organic phase was dried over
sodium sulphate. The organic phase was then ﬁltered and evaporated to dryness.
The product was subsequently puriﬁed using silica chromatography and was dried
as a crystalline white solid.
Turnover of 4MU reporter compounds by M. bovis BCG. To test turnover of
4MU-GlcNAc or 4MU-D-lactate by whole cells, 100 µL of a mid-exponential cul-
ture (OD600= 0.6) was added to a sterile 96-well plate in Sauton’s minimal media
supplemented with 0.05% Tween and 1% glycerol in addition to 1 mM 4MU-D-
lactate or 4MU-GlcNAc. Similar controls lacking cells or the reporter compound
were included as well. This was incubated at 37 °C and mixed at 300 rpm. On the
indicated days the 4MU ﬂuorescence of the sample was read on a BMC PolarStar
microplate reader with a constant gain setting.
Turnover of M. bovis BCG PG in vitro. Cultures of M. bovis BCG wild-type, ΔlpqI,
and ΔlpqI::lpqI were grown to an OD600 of 0.6 in the presence of 10 µCi 3H meso-
DAP, at which point they were collected by centrifugation, washed three times with
sterile media and diluted to 0.01 in fresh culture ﬂasks. Periodically a sample of 0.5mL
was taken, and the cells were collected by centrifugation. The spent medium was
mixed with 10mL scintillation ﬂuid and counted using a liquid scintillation counter.
The cell pellet was resuspended in 10% SDS, boiled for 20min, and centrifuged again.
The cell wall material was then resuspended in 1mL scintillation ﬂuid and the material
was counted in a liquid scintillation counter. The counts of the cell wall and the media
were added together to give total 3H DAP in each culture and the data is presented as
a percentage of that total. During the course of the experiment the OD600 of the
culture was monitored daily. All measurements are from three biological replicates.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The atomic coordinates and structure factors of LpqI are available from Protein Data
Bank with accession code 6GFV. All data used to generate the ﬁgures are available in the
Source Data ﬁle. Other data that support the ﬁndings of this study are available from the
authors on request.
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